4.7 Article

ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination

期刊

SCIENTIFIC REPORTS
卷 6, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/srep26494

关键词

-

资金

  1. NIH [U19-AI089987]
  2. Alliance for Lupus Research
  3. Baylor Health Care System

向作者/读者索取更多资源

The immune mechanism leading to the generation of protective antibody responses following influenza trivalent inactivated vaccine (TIV) vaccinations remains largely uncharacterized. We recently reported that TIV vaccination induced a transient increase of circulating ICOS+PD-1(+)CXCR3(+) T follicular helper (cTfh) cells in blood, which positively correlated with the induction of protective antibody responses measured at day 28. However, whether and how these T cells directly contribute to antibody response remains unclear. In this study, we analyzed the changes after TIV vaccination in the amount and the avidity of the polyclonal antibodies specific for the HA1 subunit of the pandemic H1N1 virus, and analyzed the correlation with the increase of ICOS+PD-1(+)CXCR3(+) cTfh cells. We found that both the amount and the avidity of specific antibodies rapidly increased during the first 7 days after TIV. Importantly, the increase of ICOS+PD-1(+)CXCR3(+) cTfh cells strongly correlated with the increase in the avidity of antibodies, particularly in subjects who did not have high affinity antibodies at baseline. We propose that ICOS+PD-1(+)CXCR3(+) Tfh cells directly contribute to the generation of high-avidity antibodies after TIV vaccinations by selectively interacting with high affinity B cells at extrafollicular sites.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage

Alba Escalera, Ana S. Gonzalez-Reiche, Sadaf Aslam, Ignacio Mena, Manon Laporte, Rebecca L. Pearl, Andrea Fossati, Raveen Rathnasinghe, Hala Alshammary, Adriana van de Guchte, Keith Farrugia, Yiren Qin, Mehdi Bouhaddou, Thomas Kehrer, Lorena Zuliani-Alvarez, David A. Meekins, Velmurugan Balaraman, Chester McDowell, Jurgen A. Richt, Goran Bajic, Emilia Mia Sordillo, Marion Dejosez, Thomas P. Zwaka, Nevan J. Krogan, Viviana Simon, Randy A. Albrecht, Harm van Bakel, Adolfo Garcia-Sastre, Teresa Aydillo

Summary: This study characterized the spike polymorphisms of the emerging SARS-CoV-2 variants and investigated their impact on transmissibility and virus pathogenicity. The findings showed that specific substitutions enhance viral replication and spike protein cleavage, leading to increased transmission efficiency in infection models and human airway systems.

CELL HOST & MICROBE (2022)

Article Virology

Functional Effects of Cardiomyocyte Injury in COVID-19

Mustafa M. Siddiq, Angel T. Chan, Lisa Miorin, Arjun S. Yadaw, Kristin G. Beaumont, Thomas Kehrer, Anastasija Cupic, Kris M. White, Rosa E. Tolentino, Bin Hu, Alan D. Stern, Iman Tavassoly, Jens Hansen, Robert Sebra, Pedro Martinez, Som Prabha, Nicole Dubois, Christoph Schaniel, Rupa Iyengar-Kapuganti, Nina Kukar, Gennaro Giustino, Karan Sud, Sharon Nirenberg, Patricia Kovatch, Randy A. Albrecht, Joseph Goldfarb, Lori Croft, Maryann A. McLaughlin, Edgar Argulian, Stamatios Lerakis, Jagat Narula, Adolfo Garcia-Sastre, Ravi Iyengar

Summary: COVID-19 affects multiple organs, including the heart, with significant numbers of patients developing cardiac dysfunction even without prior heart disease. The study suggests that interleukins and SARS-CoV-2 infection may directly impact cardiomyocytes, leading to heart disease in COVID-19 patients.

JOURNAL OF VIROLOGY (2022)

Article Cell Biology

Limited extent and consequences of pancreatic SARS-CoV-2 infection

Verena van der Heide, Sonia Jangra, Phillip Cohen, Raveen Rathnasinghe, Sadaf Aslam, Teresa Aydillo, Daniel Geanon, Diana Handler, Geoffrey Kelley, Brian Lee, Adeeb Rahman, Travis Dawson, Jingjing Qi, Darwin D'Souza, Seunghee Kim-Schulze, Julia K. Panzer, Alejandro Caicedo, Irina Kusmartseva, Amanda L. Posgai, Mark A. Atkinson, Randy A. Albrecht, Adolfo Garcia-Sastre, Brad R. Rosenberg, Michael Schotsaert, Dirk Homann

Summary: In this study, comprehensive single-cell analysis of SARS-CoV-2-infected human pancreatic islets revealed that the infection is strictly dependent on the ACE2 receptor and targets various pancreatic cell types. However, the infection is limited and non-cytopathic, causing only mild cellular perturbations and inflammatory responses. Similar outcomes were observed with endemic coronaviruses. Further evaluation is needed to determine if COVID-19-induced damage to the pancreas and immunological changes increase the risk of diabetes.

CELL REPORTS (2022)

Review Microbiology

Advances and gaps in SARS-CoV-2 infection models

Cesar Munoz-Fontela, Lina Widerspick, Randy A. Albrecht, Martin Beer, Miles W. Carroll, Emmie de Wit, Michael S. Diamond, William E. Dowling, Simon G. P. Funnell, Adolfo Garcia-Sastre, Nora M. Gerhards, Rineke de Jong, Vincent J. Munster, Johan Neyts, Stanley Perlman, Douglas S. Reed, Juergen A. Richt, Ximena Riveros-Balta, Chad J. Roy, Francisco J. Salguero, Michael Schotsaert, Lauren M. Schwartz, Robert A. Seder, Joaquim Segales, Seshadri S. Vasan, Ana Maria Henao-Restrepo, Dan H. Barouch

Summary: Animal models play a crucial role in evaluating the virulence, transmission, and immune escape of SARS-CoV-2 variants and are continuously being improved to better replicate the demographic characteristics of COVID-19.

PLOS PATHOGENS (2022)

Article Cell Biology

Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations

Noah Pena, Wen Zhang, Christopher Watkins, Mateusz Halucha, Hala Alshammary, Matthew M. Hernandez, Wen-Chun Liu, Randy A. Albrecht, Adolfo Garcia-Sastre, Viviana Simon, Christopher Katanski, Tao Pan

Summary: This study analyzes host RNAs in SARS-CoV-2 viral preparations, showing selective enrichment of specific host tRNAs, tRNA fragments, and signal recognition particle (SRP) RNA. Different viral preparations contain the same set of host RNAs, suggesting a common packaging mechanism. The study also identifies differences in tRNA modifications between viral preparations and uninfected host cells, as well as uncharacterized modifications in SARS-CoV-2 genomic RNA.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Medicine, Research & Experimental

CXCL13-producing CD4+T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

Masayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi, Koji Yamanoi, Shiro Takamatsu, Akihiko Ueda, Haruka Suzuki, Yuko Hosoe, Yoko Furutake, Mana Taki, Kaoru Abiko, Ken Yamaguchi, Hidekatsu Nakai, Tsukasa Baba, Noriomi Matsumura, Akihiko Yoshizawa, Hideki Ueno, Masaki Mandai

Summary: The formation of tertiary lymphoid structures (TLS) is associated with CXCL13-producing CD4+ T cells, and TLS facilitates the coordinated antitumor response of cellular and humoral immunity in ovarian cancer.

JCI INSIGHT (2022)

Article Microbiology

Detection of Velogenic Avian Paramyxoviruses in Rock Doves in New York City, New York

Isabel Francisco, Shatoni Bailey, Teresa Bautista, Djenabou Diallo, Jesus Gonzalez, Joel Gonzalez, Ericka Kirkpatrick Roubidoux, Paul Kehinde Ajayi, Randy A. Albrecht, Rita McMahon, Florian Krammer, Christine Marizzi

Summary: This study describes the screening of avian paramyxovirus 1 (APMV-1) in the wild bird population of New York City, identifying two diverse strains and conducting genetic analysis. The findings are important for vaccine development and poultry husbandry practices.

MICROBIOLOGY SPECTRUM (2022)

Article Neurosciences

T cells from MS Patients with High Disease Severity Are Insensitive to an Immune-Suppressive Effect of Sulfatide

Mio Hamatani, Hirofumi Ochi, Kimitoshi Kimura, Shinji Ashida, Yuichiro Hashi, Yoichiro Okada, Chihiro Fujii, Kazuyuki Kawamura, Toshiki Mizuno, Hideki Ueno, Ryosuke Takahashi, Takayuki Kondo

Summary: Sulfatide has a suppressive effect on T cell proliferation, but this effect is impaired in patients with progressive multiple sclerosis. This may contribute to disease progression, and further research provides insights into the mechanisms of disease development. This is of great importance for the treatment of multiple sclerosis.

MOLECULAR NEUROBIOLOGY (2022)

Article Immunology

A circulating subset of iNKT cells mediates antitumor and antiviral immunity

Guangwei Cui, Akihiro Shimba, Jianshi Jin, Taisaku Ogawa, Yukiko Muramoto, Hitoshi Miyachi, Shinya Abe, Takuma Asahi, Shizue Tani-Ichi, Johannes M. Dijkstra, Yayoi Iwamoto, Kirill Kryukov, Yuanbo Zhu, Daichi Takami, Takahiro Hara, Satsuki Kitano, Yan Xu, Hajime Morita, Moyu Zhang, Lynn Zreka, Keishi Miyata, Takashi Kanaya, Shinya Okumura, Takashi Ito, Etsuro Hatano, Yoshimasa Takahashi, Hiroshi Watarai, Yuichi Oike, Tadashi Imanishi, Hiroshi Ohno, Toshiaki Ohteki, Nagahiro Minato, Masato Kubo, Georg A. Hollander, Hideki Ueno, Takeshi Noda, Katsuyuki Shiroguchi, Koichi Ikuta

Summary: This study reveals a circulating subset of iNKT cells, C2 iNKT cells, with NK cell-like properties distinct from conventional tissue-resident iNKT cells. C2 iNKT cells protect against tumor metastasis and promote antiviral immune responses.

SCIENCE IMMUNOLOGY (2022)

Article Rheumatology

Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2

Shigeo Yoshida, Kohei Nishitani, Hiroyuki Yoshitomi, Shinichi Kuriyama, Shinichiro Nakamura, Takayuki Fujii, Motoo Saito, Yu Kobori, Akinori Murakami, Koichi Murata, Hiromu Ito, Hideki Ueno, Shuichi Matsuda

Summary: This study aimed to investigate the impact of high tibial osteotomy (HTO) on the intraarticular microenvironment of osteoarthritic (OA) knees. The results showed that HTO attenuated synovial inflammation and changed macrophage polarization, suggesting an improved intraarticular environment.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Chemistry, Medicinal

SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules

Alvaro Simba-Lahuasi, Angel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M. Luis Rodriguez, Vicente Marchan, Kris M. White, Adolfo Garcia-Sastre, Jose Gallego

Summary: Researchers have identified and characterized RNA-binding compounds that can inhibit the replication of SARS-CoV-2. These compounds were discovered by screening a small library of antiviral compounds and showed promising activity against SARS-CoV-2. Further investigation revealed that these compounds recognize conserved RNA elements in the SARS-CoV-2 genome. These findings provide new possibilities for developing RNA-targeted antivirals and therapeutic agents against coronaviruses.

PHARMACEUTICALS (2022)

Article Chemistry, Physical

Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas

Shivem B. Shah, Christopher R. Carlson, Kristine Lai, Zhe Zhong, Grazia Marsico, Katherine M. Lee, Nicole E. Felix Velez, Elisabeth B. Abeles, Mayar Allam, Thomas Hu, Lauren D. Walter, Karen E. Martin, Khanjan Gandhi, Scott D. Butler, Rishi Puri, Angela L. McCleary-Wheeler, Wayne Tam, Olivier Elemento, Katsuyoshi Takata, Christian Steidl, David W. Scott, Lorena Fontan, Hideki Ueno, Benjamin D. Cosgrove, Giorgio Inghirami, Andres J. Garcia, Ahmet F. Coskun, Jean L. Koff, Ari Melnick, Ankur Singh

Summary: Using synthetic-hydrogel-based organoids, researchers identified that cellular and biophysical factors in the lymphoid tumor microenvironment (Ly-TME) dampen the efficacy of targeted therapies for DLBCL. Combinatorial inhibition of multiple aberrant signaling pathways showed higher antitumor efficacy in lymphoid organoids and implanted patient tumors. These studies define the crosstalk between malignant ABC-DLBCL cells and Ly-TME and provide rational combinatorial therapies to overcome treatment resistance mediated by Ly-TME.

NATURE MATERIALS (2023)

Article Immunology

Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs

Sadaf Aslam, Madhusudan Rajendran, Divya Kriti, Andrew Kurland, Jeffrey Johnson, Harm van Bakel, Florian Krammer, Adolfo Garcia-Sastre, Juan Ayllon

Summary: To improve the production yield of seasonal influenza vaccines, we have identified optimal vaccine seed virus backbones for influenza B virus through research and evaluation in embryonated eggs. This study includes 71 strains of influenza B virus from 1940 to the present, representing the known temporal and genetic variability. By assessing the growth profiles and effectiveness of these strains, we selected three strains with the best performance as vaccine seed virus backbones to increase the production yield of influenza B virus seasonal vaccines.

NPJ VACCINES (2023)

Article Immunology

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

Sonia Jangra, Jeffrey J. Landers, Gabriel Laghlali, Raveen Rathnasinghe, Prajakta Warang, Seok-Chan Park, Jessica. J. O'Konek, Gagandeep Singh, Katarzyna W. Janczak, Adolfo Garcia-Sastre, Nandini Arya, Dilara Karadag, Jr James R. Baker, Michael Schotsaert, Pamela T. Wong

Summary: Multiple FDA-approved vaccines provide good protection against severe disease caused by SARS-CoV-2. However, immunity can decline quickly, especially in the elderly, and new viral variants are emerging that can evade the immune response induced by infection or vaccination. Intranasal vaccination is more effective in inducing mucosal immune responses than injectable vaccines, which can improve protection and reduce viral transmission.

NPJ VACCINES (2023)

Review Immunology

Engineering Non-Human RNA Viruses for Cancer Therapy

Vicent Tur-Planells, Adolfo Garcia-Sastre, Sara Cuadrado-Castano, Estanislao Nistal-Villan

Summary: This review provides an overview of non-human-adapted RNA viruses used in cancer therapy and the diverse strategies employed to optimize their therapeutic capabilities. Through this article, we gain insights into the promising advancements in virotherapy and its potential to revolutionize cancer treatment.

VACCINES (2023)

暂无数据